Atlas Trials

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Clinical trial NCT03860376 · COMPLETED

Trial details

NCT number
NCT03860376
Sponsor
Florida International University
Status
COMPLETED
Study type
OBSERVATIONAL
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell LymphomaRefractory Childhood Acute Lymphoblastic LeukemiaRefractory Childhood Hodgkin LymphomaRefractory Childhood Malignant Germ Cell NeoplasmRecurrent Childhood Brain TumorRecurrent Childhood Brainstem GliomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Soft Tissue SarcomaRecurrent Childhood EpendymomaRecurrent Childhood Lymphoblastic Lymphoma
Start date
2019-02-21
Primary completion
2022-12-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.